Hepatotoxic Effects of Lipid-Altering Agents

被引：0
|
作者：
Korth, Christine E. [1 ]
Backes, James M. [2 ,3 ]
机构：
[1] Nebraska Med Ctr, Omaha, NE 68198 USA
[2] Univ Kansas, Med Ctr, Sch Pharm & Med, Pharm Practice, Kansas City, KS 66103 USA
[3] Univ Kansas, Med Ctr, Atherosclerosis & LDL Apheresis Ctr, Kansas City, KS 66103 USA
来源：
US PHARMACIST | 2012年 / 37卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：HS17 / HS20
页数：4
相关论文
共 50 条
  • [1] Lipid-altering agents: the future
    Wierzbicki, AS
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (11) : 1063 - 1072
  • [2] Lipid-altering effects of different formulations of hydroxypropylmethylcellulose
    Maki, Kevin C.
    Carson, Michael L.
    Anderson, W. H. Kerr
    Geohas, Jeffrey
    Reeves, Matthew S.
    Farmer, Mildred V.
    Turowski, Maciej
    Miller, Marvin
    Kaden, Valerie N.
    Dicklin, Mary R.
    Rains, Tia M.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2009, 3 (03) : 159 - 166
  • [3] Atherosclerotic Cardiovascular Disease in Women: Providing Protection With Lipid-altering Agents
    Hiles, Megan
    Simmons, Ashley
    Hilleman, Daniel
    Gibson, Cheryl A.
    Backes, James M.
    CLINICAL THERAPEUTICS, 2023, 45 (11) : 1127 - 1136
  • [4] Lipid-Altering Therapy and Atrial Fibrillation
    Bachmann, Justin M.
    Majmudar, Maulik
    Tompkins, Christine
    Blumenthal, Roger S.
    Marine, Joseph E.
    CARDIOLOGY IN REVIEW, 2008, 16 (04) : 197 - 204
  • [5] Drug interactions of lipid-altering drugs
    Bays, HE
    Dujovne, CA
    DRUG SAFETY, 1998, 19 (05) : 355 - 371
  • [6] Lipid-altering drugs in development.
    Bays H.E.
    Dujovne C.A.
    Drugs in R & D, 1999, 1 (6) : 463 - 469
  • [7] Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia
    Sakabe, K
    Fukuda, N
    Wakayama, K
    Nada, T
    Shinohara, H
    Tamura, Y
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (04): : 497 - 500
  • [8] Effects of lipid-altering treatment in diabetes Mellitus and the metabolic syndrome
    Deedwania, PC
    Hunninghake, DB
    Bays, H
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (11): : 18C - 26C
  • [9] Drug Interactions of Lipid-Altering Drugs
    Harold E. Bays
    Carlos A. Dujovne
    Drug Safety, 1998, 19 : 355 - 371
  • [10] Effects of Lipid-Altering Therapies on Ventricular Arrhythmias and Sudden Cardiac Death
    Majmudar, Maulik D.
    Tompkins, Christine
    Bachmann, Justin M.
    Blumenthal, Roger S.
    Marine, Joseph E.
    CARDIOLOGY IN REVIEW, 2009, 17 (02) : 60 - 69
12345